• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

Where is everyone going?


<















The exodus began in 2018 and will continue. Horrible managers on the MS side, unattainable goals in a crowded market, lack of a pipeline, an Alzheimers drug they are trying to grift past the FDA with suspect data and horrible toxic home office leadership..... what's here to stay for?? Too many great opportunities in the industry right now to stay on a sinking ship....
 




The exodus began in 2018 and will continue. Horrible managers on the MS side, unattainable goals in a crowded market, lack of a pipeline, an Alzheimers drug they are trying to grift past the FDA with suspect data and horrible toxic home office leadership..... what's here to stay for?? Too many great opportunities in the industry right now to stay on a sinking ship....
2018? More like 2015......
 












Similar threads

Replies
26
Views
9K
Biogen
anonymous
Replies
14
Views
2K
Biogen
anonymous
Replies
4
Views
1K
Biogen
anonymous
Replies
20
Views
3K
Biogen
anonymous